Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

6.12
+0.31005.34%
Post-market: 6.11-0.0099-0.16%19:30 EDT
Volume:464.46K
Turnover:2.80M
Market Cap:366.47M
PE:-6.12
High:6.25
Open:5.87
Low:5.76
Close:5.81
52wk High:6.25
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:1.09
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:18.97
PE(LYR):-5.52

Loading ...

Orchestra BioMed Shares Rise After BTIG Upgrade

MT Newswires Live
·
Sep 11

Top Midday Gainers

MT Newswires Live
·
Sep 11

BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10

MT Newswires Live
·
Sep 10

Orchestra Biomed Holdings Inc : Btig Raises to Buy from Neutral

THOMSON REUTERS
·
Sep 10

Orchestra BioMed Holdings Price Target Announced at $10.00/Share by BTIG

Dow Jones
·
Sep 10

Top Exec Makes Bold Insider Move at Orchestra BioMed Holdings

TIPRANKS
·
Sep 09

Orchestra BioMed Highlights $500 Million-Plus Annual Royalty Potential from Medtronic-Partnered AVIM Pacemaker Therapy

Reuters
·
Sep 08

Orchestra BioMed CEO, Chair David P. Hochman Buys $47,900 Common Shares

Reuters
·
Sep 08

Orchestra BioMed COO, Director Darren Sherman Disposes of 15,000 Common Shares for $74,100

Reuters
·
Sep 03

Orchestra BioMed Grants 133,000 Inducement Stock Options to Seven New Hires Under 2025 Plan

Reuters
·
Sep 03

Orchestra Biomed Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 03

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Orchestra BioMed COO Darren Sherman Reports Acquisition of 2,000 Common Shares Valued at $10,660

Reuters
·
Aug 29

Orchestra BioMed CEO Hochman Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Aug 27

Orchestra BioMed CEO Hochman Presents at Wells Fargo Healthcare Conference

Reuters
·
Aug 20

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
Aug 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Stereotaxis Q2 Revenue Misses Estimates, Dragged by System Decline

Reuters
·
Aug 12

Orchestra BioMed price target raised to $10 from $9 at Piper Sandler

TIPRANKS
·
Aug 11

Orchestra BioMed Holdings (OBIO) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 11